Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
770 hedge funds and large institutions have $47B invested in Allergan Inc in 2014 Q2 according to their latest regulatory filings, with 149 funds opening new positions, 145 increasing their positions, 388 reducing their positions, and 108 closing their positions.
111% more funds holding in top 10
Funds holding in top 10: 35 → 74 (+39)
42% more capital invested
Capital invested by funds: $33B → $47B (+$14B)
38% more first-time investments, than exits
New positions opened: 149 | Existing positions closed: 108
5% more funds holding
Funds holding: 733 → 770 (+37)
18% less call options, than puts
Call options by funds: $1.04B | Put options by funds: $1.27B
63% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 388
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSCM
Pershing Square Capital Management
New York
|
+$4.4B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.3B |
| 3 |
PC
Paulson & Co
New York
|
+$872M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$610M |
| 5 |
MCM
Mason Capital Management
New York
|
+$427M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.33B |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$1.86B |
| 3 |
Jennison Associates
New York
|
-$962M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$767M |
| 5 |
Bank of New York Mellon
New York
|
-$318M |
AGN Hedge Fund Activity: Q2 2014 in Review
770 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2014, worth a combined $47B — up 42% from $33B a quarter earlier.
Buyers outnumbered sellers: 149 funds opened new AGN positions and 108 closed out — a net gain of 41 holders — while 145 added to existing stakes and 388 trimmed.
The largest buyer was Pershing Square Capital Management, adding an estimated $4.4B. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $2.33B sold.
- 770 institutional investors held Allergan Inc (AGN) as of Q2 2014, up from 733 in Q1 2014.
- Funds reported $47B of Allergan Inc stock for Q2 2014, up 42% quarter-over-quarter.
- 149 funds opened new Allergan Inc positions in Q2 2014 and 108 closed out, a net change of +41 holders.
- The largest Allergan Inc buyer in Q2 2014 was Pershing Square Capital Management, an estimated $4.4B added.
- The largest Allergan Inc seller in Q2 2014 was Capital Research Global Investors, an estimated $2.33B sold.
Based on aggregated 13F filings for Q2 2014.